Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fusion Animal Health is a veterinary biotechnology company specializing in regenerative medicine for performance animals and companion pets. The company's flagship product, Renovo, is an acellular equine amniotic liquid allograft designed to support the body's natural healing process in soft tissue and joint injuries. By leveraging the innate regenerative properties of amniotic tissues, Fusion Animal Health provides non-surgical, minimally invasive solutions for veterinarians to treat musculoskeletal conditions in horses and dogs. The company operates as the primary commercial division of Equi-Stem, focusing on innovative biologic therapies that reduce inflammation and promote tissue repair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fusion Animal Health.